Patents by Inventor James Adshead

James Adshead has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6841350
    Abstract: A method of diagnosing prostate cancer in a human patient comprising the steps of obtaining a sample containing nucleic acid and/or protein from prostate cells of a patient, and determining whether the sample contains a level of Pax 2 nucleic acid or protein associated with prostate cancer. A method of treating prostate cancer comprising the step of administering to the patient an agent which selectively prevents the function of Pax 2. A genetic construct comprising a nucleic acid encoding a molecule capable of preventing the function of Pax 2 expressed in a prostate cell.
    Type: Grant
    Filed: August 20, 2001
    Date of Patent: January 11, 2005
    Assignee: The North West London Hospitals NHS Trust of Northwick Park Hospital
    Inventors: Christopher William Ogden, James Adshead, Anna Maria Kessling, Bijan Khoubehi
  • Publication number: 20020142320
    Abstract: A method of diagnosing prostate cancer in a human patient comprising the steps of obtaining a sample containing nucleic acid and/or protein from prostate cells of a patient, and determining whether the sample contains a level of Pax 2 nucleic acid or protein associated with prostate cancer. A method of treating prostate cancer comprising the step of administering to the patient an agent which selectively prevents the function of Pax 2. A genetic construct comprising a nucleic acid encoding a molecule capable of preventing the function of Pax 2 expressed in a prostate cell.
    Type: Application
    Filed: August 20, 2001
    Publication date: October 3, 2002
    Inventors: Christopher William Ogden, James Adshead, Anna Maria Kessling, Bijan Khoubehi